SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Intel VP: “We’re just not going to accept subpar products”

Intel’s decision to keep NEX signals stability for Israel’s 350 networking staff

From textile recycling to autonomous vessels: The vision behind the Dream Team startups

ELNET: German business leaders “are looking with admiration and respect towards the Startup Nation”

Buzz

Most popular

Daily

Weekly

1

“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals

2

Unit 8200 veterans raise $22 million Series A for real-time impersonation defense

3

Cybereason founders' 7AI raises record $130 million Series A in breakneck rise

4

Check Point raises $1.75 billion, potentially eyeing AI expansion

5

Nice puts Actimize up for sale at a $1.5-2 billion price tag

Colossal Biosciences

1 stories about Colossal Biosciences

Sam Lamm holding Romulus, one of the cubs

"We took a 73,000-year-old fossil and created puppies from it. It's just magic"

02.06.25|Roni Dori

Biotech venture Colossal Biosciences stunned the world in April with the announcement that it had genetically engineered the dire wolf, a species that went extinct 12,500 years ago. But the excitement over the birth of three white puppies was quickly tempered by criticism: skeptics argued this was not a true species revival and warned that such investments could divert attention and resources from the urgent effort to protect existing wildlife. In an exclusive interview, founder Ben Lamm explains how the complex process was achieved, and why he believes it could ultimately benefit the planet.